Clinical utility of the combined use of plurime tumor markers in human breast cancer.
Many biological substances are commonly used as markers for malignant neoplasms, but no single marker with high specificity and sensitivity has been found for cancer to date. In this study we evaluated simultaneously the serum levels of five biomarkers of malignancy: phosphohexose-isomerase (PHI), creatine kinase isoenzyme BB (CK-BB), alpha 1-acid glycoprotein (AAG), beta 2-microglobulin (BMG), and ferritin. In 89 female patients with breast lesions, we identified 30 benign lesions, 32 primary breast cancers, and 27 metastatic breast cancers (pulmonary and/or bone metastases). Each marker was assayed individually and in a combination and was compared with other markers. The results revealed that in benign lesions only 7% had PHI values higher than our cut-off limit value, while 3% had elevated values of AAG, BMG, and ferritin. In primary breast cancer we discovered pathological values of CK-BB and AAG in 71%, of PHI in 69%, of BMG in 50%, and of ferritin in 47%. Metastatic disease was associated with elevated values in 88% of CK-BB, in 70% of PHI and AAG, and in only 55% of BMG and ferritin. Combined pathological values for primary and metastatic breast cancer were 79% for CK-BB, 71% for AAG, 70% for PHI, and only 55% for BMG and ferritin. These data were assessed by the Student t test, which revealed for each marker a significant capacity (P less than 0.01) to discriminate between benign lesions and neoplastic diseases. The same capacity to distinguish between primary and metastatic cancer was obtained by the simultaneous use of three markers (CK-BB, PHI, and AAG).(ABSTRACT TRUNCATED AT 250 WORDS)
Neri
B
B
Institute of Clinical Medicine IV, Florence University, Italy.
Bartalucci
S
S
Cataliotti
L
L
Distante
V
V
Tommasi
M
M
Ciapini
A
A
D000232:Adenofibroma / Q000175:diagnosis; D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D001943:Breast Neoplasms / Q000175:diagnosis*; D003402:Creatine Kinase / Q000097:blood; D003937:Diagnosis, Differential; D005260:Female; D005293:Ferritins / Q000097:blood; D005348:Fibrocystic Breast Disease / Q000175:diagnosis; D005956:Glucose-6-Phosphate Isomerase / Q000097:blood; D006801:Humans; D007527:Isoenzymes; D008875:Middle Aged; D009961:Orosomucoid / Q000032:analysis; D001613:beta 2-Microglobulin / Q000032:analysis
D014408:Biomarkers, Tumor; D007527:Isoenzymes; D009961:Orosomucoid; D001613:beta 2-Microglobulin; D005293:Ferritins; D003402:Creatine Kinase; D005956:Glucose-6-Phosphate Isomerase